Archon Biosciences
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 2023 Seattle business license
- Type
- Corporation Seattle business license
- Employees
- 26
- Registered name
- Archon Biosciences Inc Seattle business license
- Stage
- Seed
University of Washington CoMotion Spinoffs Launch AI, Biotech, and Mobility Innovations in Early 2025
In the first half of 2025, multiple University of Washington spinoff companies supported by CoMotion licensed UW technology to enter markets with innovations in biotech, AI education tools, and smart parking solutions. These startups benefited from CoMotion’s development programs and grants to advance their technologies from lab research to commercial applications.
Seattle Biotechs Including Archon and Cyrus Highlight AI's Promise and Pitfalls in Drug Development at 2025 Conference
Seattle biotech leaders at a 2025 conference acknowledged AI's significant potential in drug development while cautioning against overhype. Companies like Archon Biosciences and Cyrus Biotechnology are applying AI to innovate protein design and drug immunogenicity.
Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model
Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.
Archon's Jamie Lazarovits on Unlocking the Full Power of Antibodies With AI
What does it take to move from cutting-edge academic research to launching a biotech company that could transform medicine? In this week's episode of Founded & Funded, Madrona Partner Chris Picardo sat down with Jamie Lazarovitz, CEO and co-founder of Archon Biosciences, to uncover the story behind their groundbreaking protein-based biologics and their unique Antibody Cages (AbCs). From bootstrapping deep tech investments as a student to navigating the challenges of commercializing revolutionary science, Jamie shares the pivotal moments, tough decisions, and key lessons that led to Archon's creation. This isn't just a story for biotech enthusiasts — every founder can…
Archon Biosciences Raises $20M to Develop AI-Optimized Antibody Cages for Disease Treatment
Archon Biosciences has emerged from stealth with $20 million in seed funding led by Madrona Ventures to develop Antibody Cages, computationally designed protein structures optimized with AI for treating cancer and other diseases. The technology builds on protein design research linked to a recent Nobel Prize awarded to University of Washington biochemist David Baker.
Chris Picardo: Madrona Partner on Tech-Driven Life Science Innovation
Chris Picardo is a Partner at Madrona. Chris joined Madrona in 2017. As a partner on the investment team, Chris focuses on identifying, evaluating, and leading new investment opportunities and working closely with existing companies. Chris helps lead Madrona’s investments in companies innovating around the intersection of life and computer science through combining novel wet lab science with cutting-edge machine learning. He also helps lead investing activities in consumer technology and commerce, marketplaces, and Web3, focusing on how new technological innovations can create new consumer experiences and interactions with the digital world. Topics: - Evolution of the "Intersections of Innovation"…
Investor Spotlight: Chris Picardo on Cross-Disciplinary Innovation and Finding Unique Founders
In this episode of Founded & Funded, host Coral Garnick Ducken interviews Madrona Partner Chris Picardo for the latest Investor Spotlight. With degrees in math and English, Chris shares his unique journey into venture capital. Chris highlights the importance of cross-disciplinary skills in understanding and communicating complex concepts and what he looks for in founders, emphasizing unique worldviews and innovative approaches, particularly in AI, biotech, and consumer verticals. This is a great episode for entrepreneurs interested in working with VCs. (00:00) Introduction to Madrona Partner Chris Picardo (00:46) Chris Picardo: From Math and English to Startups (01:26) Chris's Transition to…
People
-
George Ueda Founder, Co-Founder and CTO
-
Chris Picardo Board Member
